{
    "clinical_study": {
        "@rank": "114280", 
        "arm_group": [
            {
                "arm_group_label": "subjects with infection at admission."
            }, 
            {
                "arm_group_label": "subjects without infection at admission."
            }
        ], 
        "brief_summary": {
            "textblock": "After successful screening diagnosis of cirrhosis and/or acute or chronic liver failure will\n      be made. These patients will undergo detail clinical, biochemical and microbiological\n      examination at baseline. Clinical examination and Biochemical evaluation will be done daily\n      and signs of infection will be noted. Patients will undergo microbiological screening for\n      infection every 48 hours. Patients suspected or diagnosed to be suffering from infections\n      will be treated as per ILBS (Institute of Liver and Biliary Sciences) antibiotic policy.\n      Site and etiology (bacterial and/or fungal) of infections will be noted in all patients at\n      admission in liver specialty ICU (Intensive Care Unit) and during the ICU (Intensive Care\n      Unit) stay. All the patients will be followed until discharge or death in ICU (Intensive\n      Care Unit)."
        }, 
        "brief_title": "Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cirrhosis", 
            "Acute Liver Failure", 
            "Chronic Liver Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis", 
                "Liver Failure", 
                "Liver Failure, Acute", 
                "End Stage Liver Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A clinical, radiological or histological diagnosis of cirrhosis and/or ACLF (Acute on\n             Chronic Liver Failure).\n\n          -  Age > 18years\n\n        Exclusion Criteria:\n\n          -  Previous liver transplantation.\n\n          -  Patients who died within 8 hours of ICU (Intensive Care Unit) admission.\n\n          -  Acute liver failure\n\n          -  Lack of consent\n\n          -  Patient on steroids/ or any other immunosuppressive medication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Tertiary Care Center."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01872767", 
            "org_study_id": "ACLF-ILBS-0003"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute on Chronic Liver Failure (ACLF),Cirrhosis,", 
            "Institute of Liver & Biliary Sciences (ILBS)"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": {
            "contact": {
                "email": "amrish.sahney@gmail.com", 
                "last_name": "Dr Amrish Sahney, MD", 
                "phone": "+91-011-46300000"
            }, 
            "facility": {
                "address": {
                    "city": "New Delhi", 
                    "country": "India", 
                    "state": "Delhi", 
                    "zip": "110070"
                }, 
                "name": "Institute of Liver & Biliary Sciences."
            }, 
            "investigator": {
                "last_name": "Dr Amrish Sahney, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_groups": "2", 
        "official_title": "Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure Admitted in Liver Specialty ICU (Intensive Care Unit)- An Observational Study", 
        "overall_contact": {
            "email": "amrish.sahney@gmail.com", 
            "last_name": "Dr Ambrish Sahney, MD", 
            "phone": "+91-11-01146300000"
        }, 
        "overall_contact_backup": {
            "email": "bhardwaj.ankit3@gmail.com", 
            "last_name": "Dr Ankit Bhardwaj", 
            "phone": "+91-011-46300000"
        }, 
        "overall_official": {
            "affiliation": "Institute of Liver & Biliary Sciences.", 
            "last_name": "Amrish Sahney, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Mortality within 1 month during ICU (Intensive Care Unit) stay.", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01872767"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of days stayed in ICU (Intensive Care Unit).", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Risk factors determination in development of multidrug resistance bacteria.Risk factors are defined as Nosocomial infection,HCA (Health Care Associated)infection,Recent Hospitalization.", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Proportion of patients with organ failure in both groups.", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Institute of Liver and Biliary Sciences, India", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute of Liver and Biliary Sciences, India", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}